Dr. Nikola Knežević presented our project #PRECAST on Serbian national television. Visit the following link to watch the TV show: https://www.youtube.com/watch?v=fccwBayWaSg
PRECAST PI, Dr. Nikola Knežević, participated in the management committee meeting of the COST action NETPORE. The action aims to bridge the gap between fundamental developments and practical applications of technologies based on porous materials. Research in medical applications of porous materials will be conducted through collaboration between research groups engaged in research in the field of diagnostics and controlled and…
It is a pleasure to be part of the Congress of the “Serbian Association for Cancer Research – SDIR”. We participated in an interactive poster session presenting part of the research within the PRECAST project and attended very interesting presentations, as well.
Minja Mladenović, the PRECAST team member, attended the 7th Nano Today Conference presenting her research. Within the conference, she also attended the Nano Today Author Workshop.
Read about our project on the Serbian Espreso portal: https://www.espreso.co.rs/vesti/drustvo/862075/srpski-naucnici-imaju-genijalan-izum-za-borbu-protiv-raka-drzava-finansira-projekat-ovo-mogu-biti-velike-vesti?fbclid=IwAR0BkCQHRCiiIsG4NuTabrdNlMMNNwRyVRpsnIR2D-deeIm8W9sckLrRxlk
It is our pleasure to announce that the PRECAST team has published a review paper, supported by the Science Fund of the Republic of Serbia, in the eminent Journal of Controlled Release (IF 9.776). To find out more visit: https://www.sciencedirect.com/science/article/pii/S0168365921003722?via%3Dihub#ac0005
The COST action CA20126 – Network for research, innovation and product development on porous semiconductors and oxides (NETPORE) has been approved and Dr. Nikola Knezevic is appointed as MC member. The topic of this COST action is highly relevant for the PRECAST agenda and we are looking forward to establishing strong research collaboration in the development of porous nanomaterials for a variety of…
Testing the biocompatibility of constructed nanomaterials and their activity against cancer (Glioblastoma Multiforme) cells in vitro is in progress. Thanks to Dr. Vesna Kojić and Oncology Institute of Vojvodina for supporting the PRECAST project and helping us towards reaching our goals.